Global Dutasteride Market Growth 2025-2031

October 2025 | 100 pages | ID: G4D66F89847EN
LP Information

Abstracts

The global Dutasteride market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.

United States market for Dutasteride is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Dutasteride is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Dutasteride is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Dutasteride players cover GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Dutasteride Industry Forecast? looks at past sales and reviews total world Dutasteride sales in 2024, providing a comprehensive analysis by region and market sector of projected Dutasteride sales for 2025 through 2031. With Dutasteride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dutasteride industry.

This Insight Report provides a comprehensive analysis of the global Dutasteride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dutasteride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Dutasteride market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dutasteride and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dutasteride.

This report presents a comprehensive overview, market shares, and growth opportunities of Dutasteride market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Type I
• Type II

Segmentation by Application:

• Hospital
• Drug Store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• GSK
• Bionpharma
• Rising Pharmaceuticals
• Teva
• Mylan
• Zydus
• Amneal Pharma
• Apotex
• Marksans Pharma
• Breckenridge Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Dutasteride market?
What factors are driving Dutasteride market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dutasteride market opportunities vary by end market size?
How does Dutasteride break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dutasteride Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Dutasteride by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Dutasteride by Country/Region, 2020, 2024 & 2031
2.2 Dutasteride Segment by Type
  2.2.1 Type I
  2.2.2 Type II
2.3 Dutasteride Sales by Type
  2.3.1 Global Dutasteride Sales Market Share by Type (2020-2025)
  2.3.2 Global Dutasteride Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Dutasteride Sale Price by Type (2020-2025)
2.4 Dutasteride Segment by Application
  2.4.1 Hospital
  2.4.2 Drug Store
2.5 Dutasteride Sales by Application
  2.5.1 Global Dutasteride Sale Market Share by Application (2020-2025)
  2.5.2 Global Dutasteride Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Dutasteride Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Dutasteride Breakdown Data by Company
  3.1.1 Global Dutasteride Annual Sales by Company (2020-2025)
  3.1.2 Global Dutasteride Sales Market Share by Company (2020-2025)
3.2 Global Dutasteride Annual Revenue by Company (2020-2025)
  3.2.1 Global Dutasteride Revenue by Company (2020-2025)
  3.2.2 Global Dutasteride Revenue Market Share by Company (2020-2025)
3.3 Global Dutasteride Sale Price by Company
3.4 Key Manufacturers Dutasteride Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Dutasteride Product Location Distribution
  3.4.2 Players Dutasteride Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DUTASTERIDE BY GEOGRAPHIC REGION

4.1 World Historic Dutasteride Market Size by Geographic Region (2020-2025)
  4.1.1 Global Dutasteride Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Dutasteride Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Dutasteride Market Size by Country/Region (2020-2025)
  4.2.1 Global Dutasteride Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Dutasteride Annual Revenue by Country/Region (2020-2025)
4.3 Americas Dutasteride Sales Growth
4.4 APAC Dutasteride Sales Growth
4.5 Europe Dutasteride Sales Growth
4.6 Middle East & Africa Dutasteride Sales Growth

5 AMERICAS

5.1 Americas Dutasteride Sales by Country
  5.1.1 Americas Dutasteride Sales by Country (2020-2025)
  5.1.2 Americas Dutasteride Revenue by Country (2020-2025)
5.2 Americas Dutasteride Sales by Type (2020-2025)
5.3 Americas Dutasteride Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Dutasteride Sales by Region
  6.1.1 APAC Dutasteride Sales by Region (2020-2025)
  6.1.2 APAC Dutasteride Revenue by Region (2020-2025)
6.2 APAC Dutasteride Sales by Type (2020-2025)
6.3 APAC Dutasteride Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Dutasteride by Country
  7.1.1 Europe Dutasteride Sales by Country (2020-2025)
  7.1.2 Europe Dutasteride Revenue by Country (2020-2025)
7.2 Europe Dutasteride Sales by Type (2020-2025)
7.3 Europe Dutasteride Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dutasteride by Country
  8.1.1 Middle East & Africa Dutasteride Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Dutasteride Revenue by Country (2020-2025)
8.2 Middle East & Africa Dutasteride Sales by Type (2020-2025)
8.3 Middle East & Africa Dutasteride Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dutasteride
10.3 Manufacturing Process Analysis of Dutasteride
10.4 Industry Chain Structure of Dutasteride

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Dutasteride Distributors
11.3 Dutasteride Customer

12 WORLD FORECAST REVIEW FOR DUTASTERIDE BY GEOGRAPHIC REGION

12.1 Global Dutasteride Market Size Forecast by Region
  12.1.1 Global Dutasteride Forecast by Region (2026-2031)
  12.1.2 Global Dutasteride Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Dutasteride Forecast by Type (2026-2031)
12.7 Global Dutasteride Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 GSK
  13.1.1 GSK Company Information
  13.1.2 GSK Dutasteride Product Portfolios and Specifications
  13.1.3 GSK Dutasteride Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 GSK Main Business Overview
  13.1.5 GSK Latest Developments
13.2 Bionpharma
  13.2.1 Bionpharma Company Information
  13.2.2 Bionpharma Dutasteride Product Portfolios and Specifications
  13.2.3 Bionpharma Dutasteride Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Bionpharma Main Business Overview
  13.2.5 Bionpharma Latest Developments
13.3 Rising Pharmaceuticals
  13.3.1 Rising Pharmaceuticals Company Information
  13.3.2 Rising Pharmaceuticals Dutasteride Product Portfolios and Specifications
  13.3.3 Rising Pharmaceuticals Dutasteride Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Rising Pharmaceuticals Main Business Overview
  13.3.5 Rising Pharmaceuticals Latest Developments
13.4 Teva
  13.4.1 Teva Company Information
  13.4.2 Teva Dutasteride Product Portfolios and Specifications
  13.4.3 Teva Dutasteride Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Teva Main Business Overview
  13.4.5 Teva Latest Developments
13.5 Mylan
  13.5.1 Mylan Company Information
  13.5.2 Mylan Dutasteride Product Portfolios and Specifications
  13.5.3 Mylan Dutasteride Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Mylan Main Business Overview
  13.5.5 Mylan Latest Developments
13.6 Zydus
  13.6.1 Zydus Company Information
  13.6.2 Zydus Dutasteride Product Portfolios and Specifications
  13.6.3 Zydus Dutasteride Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Zydus Main Business Overview
  13.6.5 Zydus Latest Developments
13.7 Amneal Pharma
  13.7.1 Amneal Pharma Company Information
  13.7.2 Amneal Pharma Dutasteride Product Portfolios and Specifications
  13.7.3 Amneal Pharma Dutasteride Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Amneal Pharma Main Business Overview
  13.7.5 Amneal Pharma Latest Developments
13.8 Apotex
  13.8.1 Apotex Company Information
  13.8.2 Apotex Dutasteride Product Portfolios and Specifications
  13.8.3 Apotex Dutasteride Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Apotex Main Business Overview
  13.8.5 Apotex Latest Developments
13.9 Marksans Pharma
  13.9.1 Marksans Pharma Company Information
  13.9.2 Marksans Pharma Dutasteride Product Portfolios and Specifications
  13.9.3 Marksans Pharma Dutasteride Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Marksans Pharma Main Business Overview
  13.9.5 Marksans Pharma Latest Developments
13.10 Breckenridge Pharmaceutical
  13.10.1 Breckenridge Pharmaceutical Company Information
  13.10.2 Breckenridge Pharmaceutical Dutasteride Product Portfolios and Specifications
  13.10.3 Breckenridge Pharmaceutical Dutasteride Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Breckenridge Pharmaceutical Main Business Overview
  13.10.5 Breckenridge Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Dutasteride Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Dutasteride Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Type I
Table 4. Major Players of Type II
Table 5. Global Dutasteride Sales by Type (2020-2025) & (K Units)
Table 6. Global Dutasteride Sales Market Share by Type (2020-2025)
Table 7. Global Dutasteride Revenue by Type (2020-2025) & ($ million)
Table 8. Global Dutasteride Revenue Market Share by Type (2020-2025)
Table 9. Global Dutasteride Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Dutasteride Sale by Application (2020-2025) & (K Units)
Table 11. Global Dutasteride Sale Market Share by Application (2020-2025)
Table 12. Global Dutasteride Revenue by Application (2020-2025) & ($ million)
Table 13. Global Dutasteride Revenue Market Share by Application (2020-2025)
Table 14. Global Dutasteride Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Dutasteride Sales by Company (2020-2025) & (K Units)
Table 16. Global Dutasteride Sales Market Share by Company (2020-2025)
Table 17. Global Dutasteride Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Dutasteride Revenue Market Share by Company (2020-2025)
Table 19. Global Dutasteride Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Dutasteride Producing Area Distribution and Sales Area
Table 21. Players Dutasteride Products Offered
Table 22. Dutasteride Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Dutasteride Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Dutasteride Sales Market Share Geographic Region (2020-2025)
Table 27. Global Dutasteride Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Dutasteride Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Dutasteride Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Dutasteride Sales Market Share by Country/Region (2020-2025)
Table 31. Global Dutasteride Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Dutasteride Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Dutasteride Sales by Country (2020-2025) & (K Units)
Table 34. Americas Dutasteride Sales Market Share by Country (2020-2025)
Table 35. Americas Dutasteride Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Dutasteride Sales by Type (2020-2025) & (K Units)
Table 37. Americas Dutasteride Sales by Application (2020-2025) & (K Units)
Table 38. APAC Dutasteride Sales by Region (2020-2025) & (K Units)
Table 39. APAC Dutasteride Sales Market Share by Region (2020-2025)
Table 40. APAC Dutasteride Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Dutasteride Sales by Type (2020-2025) & (K Units)
Table 42. APAC Dutasteride Sales by Application (2020-2025) & (K Units)
Table 43. Europe Dutasteride Sales by Country (2020-2025) & (K Units)
Table 44. Europe Dutasteride Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Dutasteride Sales by Type (2020-2025) & (K Units)
Table 46. Europe Dutasteride Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Dutasteride Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Dutasteride Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Dutasteride Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Dutasteride Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Dutasteride
Table 52. Key Market Challenges & Risks of Dutasteride
Table 53. Key Industry Trends of Dutasteride
Table 54. Dutasteride Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Dutasteride Distributors List
Table 57. Dutasteride Customer List
Table 58. Global Dutasteride Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Dutasteride Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Dutasteride Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Dutasteride Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Dutasteride Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Dutasteride Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Dutasteride Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Dutasteride Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Dutasteride Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Dutasteride Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Dutasteride Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Dutasteride Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Dutasteride Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Dutasteride Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. GSK Basic Information, Dutasteride Manufacturing Base, Sales Area and Its Competitors
Table 73. GSK Dutasteride Product Portfolios and Specifications
Table 74. GSK Dutasteride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. GSK Main Business
Table 76. GSK Latest Developments
Table 77. Bionpharma Basic Information, Dutasteride Manufacturing Base, Sales Area and Its Competitors
Table 78. Bionpharma Dutasteride Product Portfolios and Specifications
Table 79. Bionpharma Dutasteride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Bionpharma Main Business
Table 81. Bionpharma Latest Developments
Table 82. Rising Pharmaceuticals Basic Information, Dutasteride Manufacturing Base, Sales Area and Its Competitors
Table 83. Rising Pharmaceuticals Dutasteride Product Portfolios and Specifications
Table 84. Rising Pharmaceuticals Dutasteride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Rising Pharmaceuticals Main Business
Table 86. Rising Pharmaceuticals Latest Developments
Table 87. Teva Basic Information, Dutasteride Manufacturing Base, Sales Area and Its Competitors
Table 88. Teva Dutasteride Product Portfolios and Specifications
Table 89. Teva Dutasteride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Teva Main Business
Table 91. Teva Latest Developments
Table 92. Mylan Basic Information, Dutasteride Manufacturing Base, Sales Area and Its Competitors
Table 93. Mylan Dutasteride Product Portfolios and Specifications
Table 94. Mylan Dutasteride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Mylan Main Business
Table 96. Mylan Latest Developments
Table 97. Zydus Basic Information, Dutasteride Manufacturing Base, Sales Area and Its Competitors
Table 98. Zydus Dutasteride Product Portfolios and Specifications
Table 99. Zydus Dutasteride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Zydus Main Business
Table 101. Zydus Latest Developments
Table 102. Amneal Pharma Basic Information, Dutasteride Manufacturing Base, Sales Area and Its Competitors
Table 103. Amneal Pharma Dutasteride Product Portfolios and Specifications
Table 104. Amneal Pharma Dutasteride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Amneal Pharma Main Business
Table 106. Amneal Pharma Latest Developments
Table 107. Apotex Basic Information, Dutasteride Manufacturing Base, Sales Area and Its Competitors
Table 108. Apotex Dutasteride Product Portfolios and Specifications
Table 109. Apotex Dutasteride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Apotex Main Business
Table 111. Apotex Latest Developments
Table 112. Marksans Pharma Basic Information, Dutasteride Manufacturing Base, Sales Area and Its Competitors
Table 113. Marksans Pharma Dutasteride Product Portfolios and Specifications
Table 114. Marksans Pharma Dutasteride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Marksans Pharma Main Business
Table 116. Marksans Pharma Latest Developments
Table 117. Breckenridge Pharmaceutical Basic Information, Dutasteride Manufacturing Base, Sales Area and Its Competitors
Table 118. Breckenridge Pharmaceutical Dutasteride Product Portfolios and Specifications
Table 119. Breckenridge Pharmaceutical Dutasteride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Breckenridge Pharmaceutical Main Business
Table 121. Breckenridge Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Dutasteride
Figure 2. Dutasteride Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dutasteride Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Dutasteride Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Dutasteride Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Dutasteride Sales Market Share by Country/Region (2024)
Figure 10. Dutasteride Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Type I
Figure 12. Product Picture of Type II
Figure 13. Global Dutasteride Sales Market Share by Type in 2025
Figure 14. Global Dutasteride Revenue Market Share by Type (2020-2025)
Figure 15. Dutasteride Consumed in Hospital
Figure 16. Global Dutasteride Market: Hospital (2020-2025) & (K Units)
Figure 17. Dutasteride Consumed in Drug Store
Figure 18. Global Dutasteride Market: Drug Store (2020-2025) & (K Units)
Figure 19. Global Dutasteride Sale Market Share by Application (2024)
Figure 20. Global Dutasteride Revenue Market Share by Application in 2025
Figure 21. Dutasteride Sales by Company in 2025 (K Units)
Figure 22. Global Dutasteride Sales Market Share by Company in 2025
Figure 23. Dutasteride Revenue by Company in 2025 ($ millions)
Figure 24. Global Dutasteride Revenue Market Share by Company in 2025
Figure 25. Global Dutasteride Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Dutasteride Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Dutasteride Sales 2020-2025 (K Units)
Figure 28. Americas Dutasteride Revenue 2020-2025 ($ millions)
Figure 29. APAC Dutasteride Sales 2020-2025 (K Units)
Figure 30. APAC Dutasteride Revenue 2020-2025 ($ millions)
Figure 31. Europe Dutasteride Sales 2020-2025 (K Units)
Figure 32. Europe Dutasteride Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Dutasteride Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Dutasteride Revenue 2020-2025 ($ millions)
Figure 35. Americas Dutasteride Sales Market Share by Country in 2025
Figure 36. Americas Dutasteride Revenue Market Share by Country (2020-2025)
Figure 37. Americas Dutasteride Sales Market Share by Type (2020-2025)
Figure 38. Americas Dutasteride Sales Market Share by Application (2020-2025)
Figure 39. United States Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Dutasteride Sales Market Share by Region in 2025
Figure 44. APAC Dutasteride Revenue Market Share by Region (2020-2025)
Figure 45. APAC Dutasteride Sales Market Share by Type (2020-2025)
Figure 46. APAC Dutasteride Sales Market Share by Application (2020-2025)
Figure 47. China Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 51. India Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Dutasteride Sales Market Share by Country in 2025
Figure 55. Europe Dutasteride Revenue Market Share by Country (2020-2025)
Figure 56. Europe Dutasteride Sales Market Share by Type (2020-2025)
Figure 57. Europe Dutasteride Sales Market Share by Application (2020-2025)
Figure 58. Germany Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 59. France Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Dutasteride Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Dutasteride Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Dutasteride Sales Market Share by Application (2020-2025)
Figure 66. Egypt Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Dutasteride Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Dutasteride in 2025
Figure 72. Manufacturing Process Analysis of Dutasteride
Figure 73. Industry Chain Structure of Dutasteride
Figure 74. Channels of Distribution
Figure 75. Global Dutasteride Sales Market Forecast by Region (2026-2031)
Figure 76. Global Dutasteride Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Dutasteride Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Dutasteride Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Dutasteride Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Dutasteride Revenue Market Share Forecast by Application (2026-2031)